Daniel Spratt and Alicia Morgans discuss clinical outcomes of patients with Gleason score 9-10 prostate cancer after definitive treatment. Long-term Survival in Men with Gleason Score 9-10 Treated ...

At ESMO 2024, Bayer will present key results from the Phase III ARANOTE trial on NUBEQA® (darolutamide) for metastatic hormone-sensitive prostate cancer and the PEACE-III study of XOFIGO® (radium-223) ...

In this review, we discuss which patients with metastatic clear cell renal cell carcinoma (mRCC) may be most suitable for frontline tyrosine kinase inhibitor (TKI) monotherapy, a treatment option ...

What We Know about Sexual Pain and IC/BPS in Women - Beyond the Abstract ...

Alicia Morgans, MD, MPH, is a Genitourinary Medical Oncologist and the Director of the Survivorship Program at Dana-Farber Cancer Institute. A clinician and investigator, she has expertise in clinical ...

Second Edition of Core Curriculum for Urologic Nursing - Jeffrey Albaugh ...

Results from a recent prostate cancer germline genetic testing (GGT) study provide strong evidence to support GGT for all patients with prostate cancer. The PROstate Cancer registry in Large patient ...

A Novel Penile Splint As Early Traction Therapy After Grafting Techniques For Peyronie's Disease - Beyond The Abstract ...

Upper urinary tract urothelial carcinomas (UTUCs) are characterized by their obscure location, insidious onset, and propensity for early muscle-invasive and lymph node metastasis, resulting in a ...

Partial Component Exchange of a Non-Infected Inflatable Penile Prosthesis Is Associated with a Higher Complication Rate - Beyond the Abstract ...